BRIGHT MINDS BIOSCIENCES INC. Increase Decrease Through Share-based Payment Transactions
BRIGHT MINDS BIOSCIENCES INC. (DRUG) reported Increase Decrease Through Share-based Payment Transactions of CAD 839.77 thousand for the 12-month period ending 2024-09-30, per its 20-F filed 2024-12-31.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2024-12-31
| Period end | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|
| 2024-09-30 | 839.77K CAD 20-F · filed 2024-12-31 |
| 2023-09-30 | 1.15M CAD 20-F · filed 2024-12-31 |
| 2022-09-30 | 875.06K CAD 20-F · filed 2024-12-31 |
| 2021-09-30 | 880.62K CAD 20-F · filed 2023-12-29 |
| 2020-09-30 | 161.30K CAD 20-F · filed 2022-12-29 |